植物产品作为免疫激活和疫苗开发的辅助剂的应用
Manshu Zou1, Chang Lei1, Dan Huang1
1Institute of Innovation and Applied Research, Hunan University of Chinese Medicine, Hunan Province, Changsha 410208, China.
Vaccine
|July 10, 2024
概括
植物辅助剂通过提高稳定性,安全性和免疫反应来提高疫苗的有效性. 这些植物性免疫增强剂为疫苗开发提供了低毒性,具有成本效益的替代方案.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 植物科学 植物科学
背景情况:
- 疫苗对传染病控制至关重要,需要抗原和辅助剂.
- 免疫辅助剂增强了疫苗的稳定性,安全性和有效性.
- 植物衍生物质提供有前途的辅助性质.
研究的目的:
- 审查植物辅助剂在疫苗中的优势和应用.
- 分析植物辅助剂的颗粒物输送系统.
- 确定植物辅助剂的挑战和未来研究方向.
主要方法:
- 文献审查和对植物辅助剂现有研究的分析.
- 对植物性免疫增强剂的特性和疗效的研究进行了审查.
- 对提高辅助剂性能的颗粒物输送系统的评估.
主要成果:
- 植物辅助剂具有低毒性,高稳定性和成本效益.
- 来自植物的辅助剂可以显著改善疫苗免疫反应.
- 颗粒物输送系统提高了植物辅助剂的性能.
结论:
- 植物辅助剂为疫苗开发提供了一个可行的和有利的选择.
- 对颗粒物输送系统的进一步研究可以优化植物辅助剂的应用.
- 来自植物的免疫辅助剂为未来的疫苗研究提供了创新的解决方案.
相关概念视频
Vaccinations
44.3K
Overview
44.3K
Antigens Involved in Adaptive Immunity
482
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
482
Active versus Passive Immunity
617
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
Active Immunity
Active immunity refers to the resistance one develops...
617
Cancer Vaccines
350
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
350
Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
T Cell Activation and Clonal Selection
697
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
697


